These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1224751)

  • 1. [Studies on the cytotoxicity of lymphocytes in ulcerative colitis].
    Kovács A; Onody K; Petrányi G
    Z Gastroenterol; 1975 Oct; 13(6):573-6. PubMed ID: 1224751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte cytotoxic activity on embroyonic colon target cell in patients with carcinoma of the colon.
    Onody K; Kovács A; Petrányi GY+PETRANYI GY
    Neoplasma; 1974; 21(3):291-5. PubMed ID: 4608237
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic effect in vitro of B lymphocytes and killer (K) cells in ulcerative colitis.
    Tomecki R
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):67-71. PubMed ID: 6968195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the spontaneous lymphocyte toxicity in colonic carcinoma].
    Eder E; Mühe E; Kratzsch G; Warnatz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1215-7. PubMed ID: 306168
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
    Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of in vitro cytotoxicity of lymphocytes from patients with chronic ulcerative colitis or granulomatous colitis for allogenic colonic epithelial cells.
    Shorter RG; Cardoza MR; ReMine SG; Spencer RJ; Huizenga KA
    Gastroenterology; 1970 May; 58(5):692-8. PubMed ID: 4910397
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on in vitro cytotoxicity of lymphocytes from patients with ulcerative and granulomatous colitis for allogeneic colonic epithelial cells, including the effects of colectomy.
    Shorter RG; Cardoza M; Spencer RJ; Huizenga KA
    Gastroenterology; 1969 Feb; 56(2):304-9. PubMed ID: 5764597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic studies in patients with Crohn disease and ulcerative colitis].
    Sauer H; Sauer D; Bendix U; Schumann B
    Allerg Immunol (Leipz); 1984; 30(1):23-33. PubMed ID: 6203390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte response to colonic antigen its role in the pathogenesis of ulcerative colitis.
    Aiso S; Asakura H; Tanaka T; Tsuchiya M
    Biochem Exp Biol; 1980; 16(3):287-94. PubMed ID: 7272091
    [No Abstract]   [Full Text] [Related]  

  • 10. The basis of immunosuppressive treatment in ulcerative colitis.
    Bläker F
    Prog Pediatr Surg; 1978; 11():41-7. PubMed ID: 625560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis.
    Hibi T; Aiso S; Yoshida T; Watanabe M; Asakura H; Tsuru S; Tsuchiya M
    Clin Exp Immunol; 1982 Jul; 49(1):75-80. PubMed ID: 7127904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autolymphocytotoxins in ulcerative colitis and carcinoma of the colon. A lesion of tolerance.
    Sion A; Friedell MT
    Int Surg; 1974 Mar; 59(3):141-6. PubMed ID: 4545121
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerative colitis, autoimmune epiphenomena, and colonic cancer.
    Watson DW
    Cancer; 1974 Sep; 34(3):suppl:867-71. PubMed ID: 4855295
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of in vitro cytotoxicity of lymphocytes from patients with ulcerative colitis and granulomatous colitis for allogeneic colonic epithelial cells using horse anti-human thymus serum.
    Shorter RG; Spencer RJ; Huizenga KA; Hallenbeck GA
    Gastroenterology; 1968 Feb; 54(2):227-31. PubMed ID: 5711906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytotoxic effect of peripheral blood lymphocytes in ulcerative colitis].
    Tomecki R
    Pol Tyg Lek; 1980 Aug; 35(34):1315-6. PubMed ID: 7443561
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
    Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
    Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
    Ebert EC; Geng X; Lin J; Das KM
    Cell Immunol; 2006 Nov; 244(1):43-9. PubMed ID: 17416356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of human IgG on the cytotoxic effect in vitro in cases of ulcerative colitis.
    Tomecki R
    Mater Med Pol; 1985; 17(2):75-8. PubMed ID: 4079472
    [No Abstract]   [Full Text] [Related]  

  • 20. Leucocytotoxicity in malignant and non-malignant colonic diseases.
    Vose BM; Moore M; Schofield PF; Dymock IW
    Clin Exp Immunol; 1975 Dec; 22(3):393-8. PubMed ID: 1225484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.